Prandial Insulin Dosing in Hospitalized Patients
- Conditions
- DiabetesAdmitting HospitalNon-critically Ill
- Interventions
- Registration Number
- NCT01101867
- Lead Sponsor
- Kathleen Dungan
- Brief Summary
The purpose of this study is to determine whether mealtime insulin results in better control of blood sugar than a fixed meal dose in hospitalized patients.
- Detailed Description
The purpose of this study is to determine whether mealtime insulin, dosed to match the intake of carbohydrates (starches or sugars) results in better control of blood sugar than a fixed meal dose in hospitalized patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 126
- general medical or minor surgical hospitalized patients
- type 2 diabetes
- blood glucose 150-400 on at least 2 occasions within 24 hours or requiring at least 20 units of insulin/day in the 24 hours prior to enrollment
-
• Major surgery, occurring within the previous 2 weeks or planned within 72 hours of study entry, including cardiothoracic, neurosurgical, and open intra-abdominal procedures (in particular, any surgery lasting over 2 hours).
- Patients receiving glucocorticoids, total parental nutrition (TPN), or tube feeds.
- Pregnancy (glucose targets differ in pregnancy). Premenopausal women not on pharmacologic contraceptives, inrauterine device (IUD), or surgical menopause will undergo pregnancy testing.
- Patients currently on IV insulin (must wait to enroll) or with planned surgical procedures in the next 72 hours for whom intravenous insulin will be likely
- Prolonged (>24 hour) strict nil per os (NPO-nothing by mouth) status (eg. small bowl obstruction). Liquid or modified consistency diets are acceptable.
- Patients for whom expected length of stay will be less than 48 hours
- Patients using subcutaneous insulin pumps
- Diabetic ketoacidosis
- End-stage renal disease on dialysis
- End-stage liver disease with cirrhosis
- Mental conditions precluding informed consent
- Potentially sensitive admissions: prisoners, HIV, suicidality
- Unable to give consent in English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Aspart flexible dose Aspart flexible dose aspart dose determined based upon carbohydrate intake. Aspart fixed dose Aspart fixed dose fixed meal dose of aspart (based upon weight or total daily insulin dose)
- Primary Outcome Measures
Name Time Method Mean Glucose day 3 Mean glucose was calculated per participant from the average of glucose values over the 7-point (pre- and post-breakfast, lunch, dinner, and bed) glucose profile at day 3
- Secondary Outcome Measures
Name Time Method Postprandial Glucose day 3 Mean postprandial glucose was calculated per participant from the average of glucose values (post-breakfast, lunch, dinner) at day 3.
Hypoglycemia 72 hour Number of patients with any hypoglycemic event (\<70 mg/dl or \<40 mg/dl)
Change in Glucose 72 hour Change in mean glucose from day 1 to day 3, measured as difference in mean glucose day 3 minus mean glucose day 1.
Treatment Satisfaction day 3 treatment satisfaction questionnaire validated in-hospital, 19 item questionnaire using 0-6 point likert scale, for minimum zero to maximum of 102 points (with 102 indicating best satisfaction). Items are summed to find the total score.
1,5-anhydroglucitol Change day 1 to day 3 change in short-term measure of glycemia
Trial Locations
- Locations (1)
The Ohio State University
🇺🇸Columbus, Ohio, United States